Trial Profile
ONO-2745 Phase II/III Study Multi-center, randomized, parallel-group, controlled study with propofol in patients undergoing surgery requiring general anesthesia
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 18 Aug 2020
Price :
$35
*
At a glance
- Drugs Remimazolam (Primary) ; Propofol
- Indications General anaesthesia
- Focus Registrational; Therapeutic Use
- Sponsors Ono Pharmaceutical
- 12 Aug 2020 According to a Paion AG media release, Mundipharma received market approval for Anerem (remimazolam) for general anesthesia in January 2020.
- 21 Dec 2018 According to a Mundipharma Corporation media release, the company has applied for manufacturing and marketing approval in Japan based on the data from this trial.
- 04 Apr 2014 New trial record